The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma

Gynecologic Oncology

Volumn 131, Issue 3, 2013, Pages 581-585

  Jutzi, Leah ^a   Hoskins, Paul ^b   Lim, Peter ^b   Aquino Parsons, Christina ^b   Tinker, Anna ^b   Kwon, Janice S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Chemotherapy; Endometrial cancer; Lymphadenectomy; Radiation therapy

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY;

CHEMOTHERAPY; ENDOMETRIAL CANCER; LYMPHADENECTOMY; RADIATION THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, ENDOMETRIOID; CHEMORADIOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84888304136     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.09.012     Document Type: Article

References (14)

1. W.T. Creasman, P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study Cancer 60 1987 2035 2041
2. W.T. Creasman, F. Odicino, P. Maisonneuve, M.A. Quinn, U. Beller, and J.L. Benedet Carcinoma of the corpus uteri. FIGO 26th Annual Report on the results of treatment in gynecological cancer Int J Gynecol Obstet 95 2006 S105 S143
3. P. Morrow, B.N. Bundy, R.J. Kurman, W.T. Creasman, P. Heller, and H.D. Homesley Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
4. H.M. Keys, J.A. Roberts, V.L. Burnetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group Study Gynecol Oncol 92 2004 744 751
5. T. Hogberg, M. Signorelli, C.F. de Olivera, R. Fossati, A.A. Lissoni, and B. Sorbe Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results from two randomized studies Eur J Cancer 46 2010 2422 2431
6. M.K.B. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
7. J.S. Kwon, F. Qiu, R. Saskin, and M.S. Carey Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer? Obstet Gynecol 114 2009 736 743
8. C.L. Creutzberg, W.L.J. van Putten, C.C. Warlam-Rodenhuis, A.C.M. van den Berghe, K.A.J. De Winter, and P.C.M. Koper Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial J Clin Oncol 22 2004 1234 1241
9. N. Susumu, S. Sagae, Y. Udagawa, K. Niwa, H. Kuramoto, and S. Satoh Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate and high risk endometrial cancer: a Japanese Gynecologic Oncology Group study Gynecol Oncol 108 2008 226 233
10. A.J. Mundt, R. McBride, J. Rotmensch, S.E. Waggoner, S.D. Yamada, and P.P. Connell Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy Int J Radiat Oncol Biol Phys 50 2001 1145 1153
11. M.E. Randall, V.L. Filiaci, H. Muss, N.M. Spirtos, R.S. Mannel, and J. Fowler Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study J Clin Oncol 24 2006 36 44
12. K. Greven, K. Winter, K. Underhill, J. Fontenesci, J. Cooper, and T. Burke Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer Gynecol Oncol 103 2006 155 159
13. C. Creutzberg Trial of radiation therapy with or without chemotherapy for endometrial, cancer (PORTEC-3) http://clinicaltrials.gov/show/NCT00411138
14. National Cancer Institute Pelvic radiation therapy or vaginal implant radiation therapy, paclitaxel, and carboplatin in treating patients with high-risk stage I or stage II endometrial cancer (GOG 249) http:// clinicaltrials.gov/show/NCT00807768